Telemedicine: a Valuable Tool in Neurodegenerative Diseases
Telemedicine: a Valuable Tool in Neurodegenerative Diseases
复制标题
DOI：
10.1007/s13670-020-00311-z
复制
发表时间：
2020-06-01
影响因子：
1.2
通讯作者：
Schneider, Ruth B.
中科院分区：
文献类型：
--
作者：
Adams, Jamie L.;Myers, Taylor L.;Schneider, Ruth B.
综述目的随着全球人口老龄化，阿尔茨海默病（AD）和帕金森病（PD）等神经退行性疾病的患病率正在上升。能够改善结果的专科护理不足，与疾病有关的残疾使亲自看医生成为负担。远程保健是改善获得保健机会的一种潜在手段。这份手稿的目的是审查最近出版的远程医疗在AD和PD。最近的调查结果远程医疗是可行的，在AD和PD患者和他们的照顾者可以接受。与亲自就诊相比，远程医疗减少了与就诊有关的旅行和时间。远程医疗可用于康复治疗、管理认知测试和支持护理人员。获得远程医疗导致病人护理的变化，包括药物调整和治疗和支持的转诊。在AD和PD中使用远程医疗可以减轻患者的负担，并增加获得专业护理的机会。扩展远程医疗保健的障碍包括缺乏广泛的宽带接入，国家许可证要求和不一致的报销。需要更多基于结果的前瞻性远程医疗研究。
Purpose of Review The prevalence of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), is rising as the global population ages. Access to specialist care, which improves outcomes, is insufficient and disease-related disability makes in-person physician visits burdensome. Telehealth is one potential means for improving access to care. The purpose of this manuscript is to review recent publications on telemedicine in AD and PD. Recent Findings Telemedicine is feasible in AD and PD and acceptable to patients and their caregivers. Compared with in-person visits, telemedicine reduces visit-associated travel and time. Telemedicine can be used for rehabilitative therapies, to administer cognitive tests, and to support caregivers. Access to telemedicine results in changes in patient care including medication adjustments and referrals for therapies and supports. The use of telemedicine in AD and PD stands to decrease burden on patients and increases access to specialty care. Barriers to the expansion of telemedicine care include lack of widespread broadband access, state licensure requirements, and inconsistent reimbursement. More outcome-based prospective telemedicine studies are needed.